Gary Cameron
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Gary Cameron has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Ahmed F. Hawwa
Clinical and Practice Research Group, School of Pharmacy, Queen's University Belfast, Belfast, United Kingdom
1 shared publication - Ajay Iyer
Conway Institute of Biomolecular Research, University College Dublin, Belfield, Ireland
1 shared publication - Baba Sulemana Mohammed
Department of Pharmacy, University for Development Studies, Tamale, Ghana
1 shared publication - Brian Joseph Anderson
Department of Anaesthesiology, University of Auckland, Auckland, New Zealand
1 shared publication - Charles S. Bestwick
University of Aberdeen, Rowett Institute
1 shared publication - Eva C. Soto-Martín
University of Aberdeen Institute of Medical Sciences
1 shared publication
Latest Publications
- Open Access
Machine learning identifies routine blood tests as accurate predictive measures of pollution-dependent poor cognitive function
Background Several modifiable risk factors for dementia and related neurodegenerative diseases have been identified including education level, socio-economic status, and environmental exposures – however, how these population-level risks relate to individual risk remains elusive. To address this, we assess over 450 potential risk factors in one deeply clinically and demographically phenotyped cohort using random forest classifiers to determine predictive markers of poor cognitive function. This study aims to understand early risk factors for dementia by identifying predictors of poor cognitive performance amongst a comprehensive battery of imaging, blood, atmospheric pollutant and socio-economic measures. Methods Random forest modelling was used to determine significant predictors of poor cognitive performance in a cohort of 324 individuals (age 61.6 ± 4.8 years; 150 males, 174 females) without extant neurological disease. 457 features were assessed including brain imaging measures of volume and iron deposition, blood measures of anaemia, inflammation, and heavy metal levels, social deprivation indicators and atmospheric pollution exposure. Results Routinely assessed markers of anaemia including mean corpuscular haemoglobin concentration were identified as robust predictors of poor general cognition, where both extremes (low and high) were associated with poor cognitive performance. The strongest, most consistent predictors of poor cognitive performance were environmental measures of atmospheric pollution, in particular, lead, carbon monoxide, and particulate matter. Feature analysis demonstrated a significant negative relationship between low mean corpuscular haemoglobin concentration and high levels of atmospheric pollutants highlighting the potential of routinely assessed blood tests as a predictive measure of pollution-dependent cognitive functioning, at an individual level. Conclusions Taken together, these data demonstrate how routine, inexpensive medical testing and local authority initiatives could help to identify and protect at-risk individuals. These findings highlight the potential to identify individuals for targeted, cost effective medical and social interventions to improve population cognitive health.
Open AccessMachine learning identifies routine blood tests as accurate predictive measures of pollution-dependent poor cognitive function
Background Several modifiable risk factors for dementia and related neurodegenerative diseases have been identified including education level, socio-economic status, and environmental exposures – however, how these population-level risks relate to individual risk remains elusive. To address this, we assess over 450 potential risk factors in one deeply clinically and demographically phenotyped cohort using random forest classifiers to determine predictive markers of poor cognitive function. This study aims to understand early risk factors for dementia by identifying predictors of poor cognitive performance amongst a comprehensive battery of imaging, blood, atmospheric pollutant and socio-economic measures. Methods Random forest modelling was used to determine significant predictors of poor cognitive performance in a cohort of 324 individuals (age 61.6 ± 4.8 years; 150 males, 174 females) without extant neurological disease. 457 features were assessed including brain imaging measures of volume and iron deposition, blood measures of anaemia, inflammation, and heavy metal levels, social deprivation indicators and atmospheric pollution exposure. Results Routinely assessed markers of anaemia including mean corpuscular haemoglobin concentration were identified as robust predictors of poor general cognition, where both extremes (low and high) were associated with poor cognitive performance. The strongest, most consistent predictors of poor cognitive performance were environmental measures of atmospheric pollution, in particular, lead, carbon monoxide, and particulate matter. Feature analysis demonstrated a significant negative relationship between low mean corpuscular haemoglobin concentration and high levels of atmospheric pollutants highlighting the potential of routinely assessed blood tests as a predictive measure of pollution-dependent cognitive functioning, at an individual level. Conclusions Taken together, these data demonstrate how routine, inexpensive medical testing and local authority initiatives could help to identify and protect at-risk individuals. These findings highlight the potential to identify individuals for targeted, cost effective medical and social interventions to improve population cognitive health.
- Open Access
Gorse ( Ulex europeaus ) wastes with 5,6-dimethyl benzimidazole supplementation can support growth of vitamin B 12 producing commensal gut microbes
Many commensal gut microbes are recognized for their potential to synthesize vitamin B 12 , offering a promising avenue to address deficiencies through probiotic supplementation. While bioinformatics tools aid in predicting B 12 biosynthetic potential, empirical validation remains crucial to confirm production, identify cobalamin vitamers, and establish biosynthetic yields. This study investigates vitamin B 12 production in three human colonic bacterial species: Anaerobu-tyricum hallii DSM 3353, Roseburia faecis DSM 16840, and Anaerostipes caccae DSM 14662, along with Propionibacterium freudenreichii DSM 4902 as a positive control. These strains were selected for their potential use as probiotics, based on speculated B 12 production from prior bioinformatic analyses. Cultures were grown in M2GSC, chemically defined media (CDM), and Gorse extract medium (GEM). The composition of GEM was similar to CDM, expect that the carbon and nitrogen source was replaced with protein-depleted liquid wastes obtained after subjecting Gorse to a leaf protein extraction process. B 12 yields were quantified using liquid chromatography with tandem mass spectrophotometry. The results suggest that the three butyrate-producing strains could indeed produce B 12 , although the yields were notably low, and with no B 12 being detected in the extracellular media. Next, GEM outperformed the conventional M2GSC growth medium in enhancing B 12 production. The positive control, P. freudenreichii DSM 4902 produced B 12 at concentrations ranging from 7 ng·mL −1 to 12 ng·mL −1 . Univariate-scaled Principal Component Analysis of data from previous publications investigating B 12 production in P. freudenreichii revealed that B 12 yields diminished when the carbon source concentration was ≤ 30 g·L −1 . In conclusion, the protein-depleted wastes from the leaf protein extraction process from Gorse can be valorised as a viable substrate for culturing B 12 -producing colonic gut microbes. Furthermore, this is the first report attesting to the ability of A. hallii, R. faecis , and A. caccae to produce B 12 . However, these microbes seem unsuitable for industrial applications owing to low B 12 yields.
Open AccessGorse ( Ulex europeaus ) wastes with 5,6-dimethyl benzimidazole supplementation can support growth of vitamin B 12 producing commensal gut microbes
Many commensal gut microbes are recognized for their potential to synthesize vitamin B 12 , offering a promising avenue to address deficiencies through probiotic supplementation. While bioinformatics tools aid in predicting B 12 biosynthetic potential, empirical validation remains crucial to confirm production, identify cobalamin vitamers, and establish biosynthetic yields. This study investigates vitamin B 12 production in three human colonic bacterial species: Anaerobu-tyricum hallii DSM 3353, Roseburia faecis DSM 16840, and Anaerostipes caccae DSM 14662, along with Propionibacterium freudenreichii DSM 4902 as a positive control. These strains were selected for their potential use as probiotics, based on speculated B 12 production from prior bioinformatic analyses. Cultures were grown in M2GSC, chemically defined media (CDM), and Gorse extract medium (GEM). The composition of GEM was similar to CDM, expect that the carbon and nitrogen source was replaced with protein-depleted liquid wastes obtained after subjecting Gorse to a leaf protein extraction process. B 12 yields were quantified using liquid chromatography with tandem mass spectrophotometry. The results suggest that the three butyrate-producing strains could indeed produce B 12 , although the yields were notably low, and with no B 12 being detected in the extracellular media. Next, GEM outperformed the conventional M2GSC growth medium in enhancing B 12 production. The positive control, P. freudenreichii DSM 4902 produced B 12 at concentrations ranging from 7 ng·mL −1 to 12 ng·mL −1 . Univariate-scaled Principal Component Analysis of data from previous publications investigating B 12 production in P. freudenreichii revealed that B 12 yields diminished when the carbon source concentration was ≤ 30 g·L −1 . In conclusion, the protein-depleted wastes from the leaf protein extraction process from Gorse can be valorised as a viable substrate for culturing B 12 -producing colonic gut microbes. Furthermore, this is the first report attesting to the ability of A. hallii, R. faecis , and A. caccae to produce B 12 . However, these microbes seem unsuitable for industrial applications owing to low B 12 yields.
- 21 December 2017
- Published by Wiley in Pediatric Anesthesia
- Vol. 28 (2) , 80-86
The pharmacokinetics of intravenous ketorolac in children aged 2 months to 16 years: A population analysis
Summary: Background: Intravenous ketorolac is commonly administered to children for the control of postoperative pain. An effect siteEC50for analgesia of 0.37 mg.L−1is described in adults.Aims: The aim of this study was to review age‐ and weight‐related effects on ketorolac pharmacokinetic parameters in children and current dosing schedules.Methods: Pooled intravenous ketorolac (0.5 mg.kg−1) concentration‐time data in children aged 2 months to 16 years were analyzed using nonlinear mixed‐effects models. Allometry was used to scale to a 70 kg person.Results: There were 64 children aged 2 months to 16 years (641 plasma concentrations) available for analysis. A two‐compartment mammillary model was used to describe pharmacokinetics. Clearance was 2.53 (CV45.9%) L.h−1.70 kg−1and intercompartment clearance was 4.43 (CV95.6%) L.h−1.70 kg−1. Both central (V1) and peripheral (V2) volumes of distribution decreased with age over the first few years of postnatal life to reach V1 6.89 (CV30.3%) L.70 kg−1and V2 5.53 (CV47.6%) L.70 kg−1.Conclusion: Clearance, expressed as L.h−1.kg−1, decreased with age from infancy. A dosing regimen of 0.5 mg.kg−1every 6 hours maintains a trough concentration larger than 0.37 mg.L−1in children 9 months to 16 years of age. This dosing regimen is consistent with current recommendations.
- 21 December 2017
- Published by Wiley in Pediatric Anesthesia
- Vol. 28 (2) , 80-86
The pharmacokinetics of intravenous ketorolac in children aged 2 months to 16 years: A population analysis
Summary: Background: Intravenous ketorolac is commonly administered to children for the control of postoperative pain. An effect siteEC50for analgesia of 0.37 mg.L−1is described in adults.Aims: The aim of this study was to review age‐ and weight‐related effects on ketorolac pharmacokinetic parameters in children and current dosing schedules.Methods: Pooled intravenous ketorolac (0.5 mg.kg−1) concentration‐time data in children aged 2 months to 16 years were analyzed using nonlinear mixed‐effects models. Allometry was used to scale to a 70 kg person.Results: There were 64 children aged 2 months to 16 years (641 plasma concentrations) available for analysis. A two‐compartment mammillary model was used to describe pharmacokinetics. Clearance was 2.53 (CV45.9%) L.h−1.70 kg−1and intercompartment clearance was 4.43 (CV95.6%) L.h−1.70 kg−1. Both central (V1) and peripheral (V2) volumes of distribution decreased with age over the first few years of postnatal life to reach V1 6.89 (CV30.3%) L.70 kg−1and V2 5.53 (CV47.6%) L.70 kg−1.Conclusion: Clearance, expressed as L.h−1.kg−1, decreased with age from infancy. A dosing regimen of 0.5 mg.kg−1every 6 hours maintains a trough concentration larger than 0.37 mg.L−1in children 9 months to 16 years of age. This dosing regimen is consistent with current recommendations.